Skip to main content

Advertisement

SpringerLink
Log in

Osseous sarcoidosis: a case series

  • Original Article - Cases with a Message
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Sarcoidosis is an inflammatory disorder characterized by noncaseating granulomas infiltrating affected organs. Any organ system can be involved, and more than 90 % of patients have a primary pulmonary manifestation. The incidence of radiographically evident bone involvement has been reported over a wide range: from 3 to 39 % depending on the population studied and imaging modalities used. Any bone may be affected in osseous sarcoidosis. Bilateral involvement of the phalanges of the hand and feet is most common. However, reports of long bone, skull, rib and vertebral involvement have appeared. To date, there are no specific tools for the assessment of skeletal disease activity in sarcoidosis. Plain radiograph picks lesions in the small bones of hands and feet greater than does in other bones. Bone scan is useful for defining the extent of the skeletal disease and bone marrow involvement. Magnetic resonance imaging usually demonstrates multifocal lesions within the vertebrae that are hypointense on T1-weighted images and hyperintense on T2-weighted images. In cases of multifocal bone lesions and an established diagnosis of sarcoidosis, a diagnosis of bone sarcoidosis should be considered in the differential diagnosis. Optimal treatment of osseous sarcoidosis remains controversial. We present five cases of multisystem sarcoidosis with skeletal involvement including long bones and vertebrae and a description of immunosuppressive therapies used in our patients. A literature review highlighting the diagnostic approach using radiographic imaging, as well as treatment strategies, is provided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. James DG, Neville E, Siltzbach LE (1976) A worldwide review of sarcoidosis. Ann NY Acad Sci 278:321–334

    Article  CAS  PubMed  Google Scholar 

  2. Shorr AF, Murphy FT, Gilliland WR, Hnatiuk W (2000) Osseous disease in patients with pulmonary sarcoidosis and musculoskeletal symptoms. Respir Med 94(3):228–232

    Article  CAS  PubMed  Google Scholar 

  3. Chatham W (2010) Rheumatic manifestations of systemic disease: sarcoidosis. Curr Opin Rheumatol 22(1):85–90

    Article  CAS  PubMed  Google Scholar 

  4. Ugwonali OF, Parisien M, Nickerson KG, Scully B, Ristic S, Strauch RJ (2005) Osseous sarcoidosis of the hand: pathologic analysis and review of the literature. J Hand Surg Am 30(4):854–858

    Article  PubMed  Google Scholar 

  5. Talmi D, Smith S, Mulligan ME (2008) Central skeletal sarcoidosis mimicking metastatic disease. Skeletal Radiol 37(8):757–761

    Article  PubMed  Google Scholar 

  6. Waanders F, van Hengel P, Krikke A, Wesseling J, Nieboer P (2006) Sarcoidosis mimicking metastatic disease: a case report and review of the literature. Neth J Med 64(9):342–345

    CAS  PubMed  Google Scholar 

  7. Fisher AJ, Gilula LA, Kyriakos M, Holzaepfel CD (1999) MR imaging changes of lumbar vertebral sarcoidosis. AJR Am J Roentgenol 173(2):354–356

    Article  CAS  PubMed  Google Scholar 

  8. Lisle D, Mitchell K, Crouch M, Windsor M (2004) Sarcoidosis of the thoracic and lumbar spine: imaging findings with an emphasis on magnetic resonance imaging. Australas Radiol 48(3):404–407

    Article  CAS  PubMed  Google Scholar 

  9. Poyanli A, Poyanli O, Sencer S, Akan K, Sayrak H, Acunaş B (2000) Vertebral sarcoidosis: imaging findings. Eur Radiol 10(1):92–94

    Article  CAS  PubMed  Google Scholar 

  10. Rúa-Figueroa I, Gantes MA, Erausquin C, Mhaidli H, Montesdeoca A (2002) Vertebral sarcoidosis: clinical and imaging findings. Semin Arthritis Rheum 31(5):346–352

    Article  PubMed  Google Scholar 

  11. Binicier O, Sari I, Sen G, Onen F, Akkoc N, Manisali M, Akar S (2009) Axial sarcoidosis mimicking radiographic sacroiliitis. Rheumatol Int 29(3):343–345

    Article  PubMed  Google Scholar 

  12. Yaghmai I (1983) Radiographic, angiographic and radionuclide manifestations of osseous sarcoidosis. RadioGraphics 3(3):375–396

    Article  Google Scholar 

  13. Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, Drent M (2012) F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med 37(1):21–25

    Article  PubMed  Google Scholar 

  14. Mostard RL, Vöö S, van Kroonenburgh MJ, Verschakelen JA, Wijnen PA, Nelemans PJ, Erckens RJ, Drent M (2011) Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 105(12):1917–1924

    Article  CAS  PubMed  Google Scholar 

  15. Sun SS, Tsai SC, Hung CJ, Tsai PP, Kao CH (2001) Tc-99m MDP and Ga-67 citrate scintigraphic findings in sarcoidosis with osseous involvement. Clin Nucl Med 26(5):472–473

    Article  CAS  PubMed  Google Scholar 

  16. Moore SL, Kransdorf MJ, Schweitzer ME, Murphey MD, Babb JS (2012) Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI? AJR Am J Roentgenol 198(6):1387–1393

    Article  PubMed  Google Scholar 

  17. Moore SL, Teirstein AE (2003) Musculoskeletal sarcoidosis: spectrum of appearances at MR imaging. Radiographics 23(6):1389–1399

    Article  PubMed  Google Scholar 

  18. Moore SL, Teirstein A, Golimbu C (2005) MRI of sarcoidosis patients with musculoskeletal symptoms. AJR Am J Roentgenol 185(1):154–159

    Article  PubMed  Google Scholar 

  19. Johns CJ, Michele TM (1999) The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 78(2):65–111

    Article  CAS  Google Scholar 

  20. Johnson AK, Johnson JM, Ames E, Filippi C (2012) Spontaneous clinical and radiological resolution of vertebral sarcoidosis: a case report. Spine (Phila Pa 1976) 37(6):E414–E416

    Article  Google Scholar 

  21. Salmon JH, Perotin JM, Direz G, Brochot P, Laredo JD, Eschard JP (2013) Vertebral sarcoidosis. Spontaneous favorable outcome: a case report and literature review. Rev Med Interne 34(1):42–46

    Article  PubMed  Google Scholar 

  22. Shorr AF, Murphy FT, Kelly WF, Kaplan KJ, Gilliland WR, Shapeero LG (1998) Osseous sarcoidosis clinical, radiographic, and therapeutic observations. J Clin Rheumatol 4(4):186–192

    Article  CAS  PubMed  Google Scholar 

  23. Wilcox A, Bharadwaj P, Sharma OP (2000) Bone sarcoidosis. Curr Opin Rheumatol 12(4):321–330

    Article  CAS  PubMed  Google Scholar 

  24. Mitchell DN (1998) Sarcoidosis with skeletal involvement. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby International, London, pp 26.1–26.8

    Google Scholar 

  25. Maña J, Gómez-Vaquero C, Dorca J, Pujol R (1999) Vertebral and rib sarcoidosis: long-term clinical remission with methotrexate. Clin Rheumatol 18(6):492–494

    Article  PubMed  Google Scholar 

  26. Sakellariou GT, Anastasilakis AD, Karanikolas D, Vounotrypidis P, Berberidis C (2013) Central skeletal sarcoidosis: a case report with sustained remission only on methotrexate, and a literature review on the imaging approach, treatment, and assessment of disease activity. Mod Rheumatol 23(1):175–181

    Article  PubMed  Google Scholar 

  27. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG (1995) Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 34(7):642–644

    Article  CAS  PubMed  Google Scholar 

  28. Lower EE, Baughman RP (1990) The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 299(3):153–157

    Article  CAS  PubMed  Google Scholar 

  29. Vucinic VM (2002) What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med 8(5):470–476

    Article  PubMed  Google Scholar 

  30. Agostini C, Adami F, Semenzato G (2000) New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12(1):71–76

    Article  CAS  PubMed  Google Scholar 

  31. Semenzato G, Pezzutto A, Chilosi M, Pizzolo G (1982) Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med 306(1):48–49

    Article  CAS  PubMed  Google Scholar 

  32. Kasahara K, Kobayashi K, Shikama Y, Yoneya I, Kaga S, Hashimoto M, Odagiri T, Soejima K, Ide H, Takahashi T et al (1989) The role of monokines in granuloma formation in mice: the ability of interleukin 1 and tumor necrosis factor-alpha to induce lung granulomas. Clin Immunol Immunopathol 51(3):419–425

    Article  CAS  PubMed  Google Scholar 

  33. Bargagli E, Mazzi A, Rottoli P (2008) Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med 29(3):445–458

    Article  CAS  PubMed  Google Scholar 

  34. Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S, Sato N (2001) IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166(1):642–649

    Article  CAS  PubMed  Google Scholar 

  35. Elliott M, Benson J, Blank M, Brodmerkel C, Baker D, Sharples KR, Szapary P (2009) Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases. Ann NY Acad Sci 1182:97–110

    Article  CAS  PubMed  Google Scholar 

  36. Larousserie F, Pflanz S, Coulomb-L’Herminé A, Brousse N, Kastelein R, Devergne O (2004) Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 202(2):164–171

    Article  CAS  PubMed  Google Scholar 

  37. Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C (2011) Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 66(2):144–150

    Article  PubMed  Google Scholar 

  38. Ramos-Casals M, Brito-Zerón P, Muñoz S, Soto MJ, BIOGEAS STUDY Group (2008) A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore) 87(6):345–364

    Article  Google Scholar 

  39. Bargagli E, Olivieri C, Rottoli P (2011) Cytokine modulators in the treatment of sarcoidosis. Rheumatol Int 31(12):1539–1544

    Article  CAS  PubMed  Google Scholar 

  40. Chen ES, Moller DR (2011) Sarcoidosis–scientific progress and clinical challenges. Nat Rev Rheumatol 7(8):457–467

    Article  CAS  PubMed  Google Scholar 

  41. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE (1990) Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 115(1):36–42

    CAS  PubMed  Google Scholar 

  42. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vuk-Pavlovic Z, Schroeder DR (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124(1):177–185

    Article  CAS  PubMed  Google Scholar 

  43. Khanna D, Liebling MR, Louie JS (2003) Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 30(8):1864–1867

    PubMed  Google Scholar 

  44. Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127(3):1064–1071

    Article  CAS  PubMed  Google Scholar 

  45. Roberts SD, Wilkes DS, Burgett RA, Knox KS (2003) Refractory sarcoidosis responding to infliximab. Chest 124(5):2028–2031

    Article  PubMed  Google Scholar 

  46. Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W Jr, Sands BE (2006) A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23(3):201–208

    PubMed  Google Scholar 

  47. Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, Benticuaga MN (2006) Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol 25(4):596–597

    Article  PubMed  Google Scholar 

  48. Baughman RP, Lower EE, Drent M (2008) Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis 25(2):76–89

    CAS  PubMed  Google Scholar 

  49. Vigne C, Tebib JG, Pacheco Y, Coury F (2013) Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy. Joint Bone Spine 80(1):104–107

    Article  PubMed  Google Scholar 

  50. Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, Samimi M, Pavy S, Pertuiset E, Toussirot E, Combe B, Morel J (2009) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Club Rhumatismes et Inflammation (CRI). Rheumatology (Oxford) 48(8):883–886

    Article  Google Scholar 

  51. Bosè F, Raeli L, Garutti C, Frigerio E, Cozzi A, Crimi M, Caprioli F, Scavelli R, Altomare G, Geginat J, Abrignani S, Reali E (2011) Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Clin Immunol 139(2):164–176

    Article  PubMed  Google Scholar 

  52. Tong D, Manolios N, Howe G, Spencer D (2012) New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication. Intern Med J 42(1):89–94

    Article  CAS  PubMed  Google Scholar 

  53. Banse C, Bisson-Vaivre A, Kozyreff-Meurice M, Vittecoq O, Goëb V (2013) No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis. Int J Gen Med 22(6):605–611

    Article  Google Scholar 

  54. Garg S, Garg K, Altaf M, Magaldi JA (2008) Refractory vertebral sarcoidosis responding to infliximab. J Clin Rheumatol 14(4):238–240

    Article  PubMed  Google Scholar 

  55. Hasni SA, Kunz D, Finzel K, Gruber BL (2010) Osseous sarcoidosis treated with tumor necrosis factor-inhibitors: case report and review of the literature. Spine 35(18):E904–E907

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Cooper University Hospital, Camden, NJ, 08103, USA

    Halyna Kuzyshyn, David Feinstein, Sharon L. Kolasinski & Hala Eid

Authors
  1. Halyna Kuzyshyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Feinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sharon L. Kolasinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hala Eid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Halyna Kuzyshyn.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuzyshyn, H., Feinstein, D., Kolasinski, S.L. et al. Osseous sarcoidosis: a case series. Rheumatol Int 35, 925–933 (2015). https://doi.org/10.1007/s00296-014-3170-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3170-4

Keywords

Search

Navigation